Cite
HARVARD Citation
Macaluso, F. et al. (n.d.). P325 A propensity score-weighted comparison of vedolizumab and adalimumab in Crohn's disease: Real-life data from the Sicilian Network for inflammatory bowel disease (SN-IBD). Journal of Crohn's and colitis. p. S316. [Online].